<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35151347</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1757-4749</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Gut pathogens</Title><ISOAbbreviation>Gut Pathog</ISOAbbreviation></Journal><ArticleTitle>Curcumin assists anti-EV71 activity of IFN-&#x3b1; by inhibiting IFNAR1 reduction in SH-SY5Y cells.</ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13099-022-00481-5</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIM" NlmCategory="OBJECTIVE">Enterovirus 71(EV71) can cause severe hand, foot, and mouth disease (HFMD) with brain tissue involvement. Few effective anti-EV71 drugs are presently available in clinical practice. Interferon-&#x3b1; (IFN-&#x3b1;) was ineffective while Curcumin was effective in restricting EV71 replication in non-neuronal cells. Ubiquitin-proteasome-mediated degradation of interferon-alpha receptor 1 (IFNAR1) protein contributes to IFN-&#x3b1; resistance. Current study aimed to determine synergistic inhibition of EV71 by Curcumin and IFN-&#x3b1; in human neuroblastoma SH-SY5Y cells.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">SH-SY5Y cells were infected with mock-/Curcumin-pre-incubated EV71 or transfected with plasmid containing interferon-stimulated response element (ISRE) or mRNA containing viral internal ribosomal entry site (IRES) following by post-treatment with Curcumin with or without IFN-&#x3b1;. Supernatant IFN-&#x3b1;/&#x3b2; was detected by ELISA. ISRE, IRSE, proteasome and deubiquitinating activity were measured by luciferase assay. EV71 RNA and viral protein or IFNAR1 were determined by qPCR and western blot, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">EV71 flailed to completely block IFN-&#x3b1;/&#x3b2; production but inhibited IFN-&#x3b1; signal. Curcumin only slightly inhibited EV71 proliferation without modulating virus attachment and internalization. However, Curcumin addition restored IFN-&#x3b1;-mediated ISRE activity thus significantly inhibiting EV71 replication. Furthermore, EV71 also reduced IFNAR1 protein with proteasome-dependence in SH-SY5Y cells, which can be reversed by Curcumin addition with the evidence that it lowered proteasome activity.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These data demonstrate that Curcumin assists anti-EV71 activity of IFN-&#x3b1; by inhibiting IFNAR1 reduction via ubiquitin-proteasome disruption in SH-SY5Y cells.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanfang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Jincheng People's Hospital, Jincheng, 048000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dan</LastName><ForeName>Kena</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Xiaoling</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Hematology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Bangtao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Chongqing University Three Gorges Hospital, Chongqing, 404100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2105-8191</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, 400030, China. dr_chench08@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Gut Pathog</MedlineTA><NlmUniqueID>101474263</NlmUniqueID><ISSNLinking>1757-4749</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Curcumin</Keyword><Keyword MajorTopicYN="N">Enterovirus 71(EV71)</Keyword><Keyword MajorTopicYN="N">Interferon alpha receptor 1 (IFNAR1)</Keyword><Keyword MajorTopicYN="N">Interferon-&#x3b1; (IFN-&#x3b1;)</Keyword><Keyword MajorTopicYN="N">Ubiquitin&#x2013;proteasome</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>13</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35151347</ArticleId><ArticleId IdType="pmc">PMC8840321</ArticleId><ArticleId IdType="doi">10.1186/s13099-022-00481-5</ArticleId><ArticleId IdType="pii">10.1186/s13099-022-00481-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guo H, Li Y, Liu G, et al. A second open reading frame in human Enterovirus determines viral replication in intestinal epithelial cells. Nat Commun. 2019;10(1):4066. doi: 10.1038/s41467-019-12040-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12040-9</ArticleId><ArticleId IdType="pmc">PMC6731315</ArticleId><ArticleId IdType="pubmed">31492846</ArticleId></ArticleIdList></Reference><Reference><Citation>Su YS, Tsai AH, Ho YF, et al. Stimulation of the internal ribosome entry site (IRES)-dependent translation of Enterovirus 71 by DDX3X RNA helicase and viral 2A and 3C proteases. Front Microbiol. 2018;9:1324. doi: 10.3389/fmicb.2018.01324.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.01324</ArticleId><ArticleId IdType="pmc">PMC6018165</ArticleId><ArticleId IdType="pubmed">29971060</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M, Khanbabaei H, Teimoori A. An update on Enterovirus 71 infection and interferon type I response. Rev Med Virol. 2019;29(1):e2016. doi: 10.1002/rmv.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2016</ArticleId><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Wang Y, Pei X, et al. Cellular caspase-3 contributes to EV-A71 2Apro-mediated down-regulation of IFNAR1 at the translation level. Virol Sin. 2020;35(1):64&#x2013;72. doi: 10.1007/s12250-019-00151-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00151-y</ArticleId><ArticleId IdType="pmc">PMC7035401</ArticleId><ArticleId IdType="pubmed">31512106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol. 2012;86(7):3767&#x2013;3776. doi: 10.1128/JVI.06687-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings MR, Parks RJ. Curcumin as an antiviral agent. Viruses. 2020;12(11):1242. doi: 10.3390/v12111242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12111242</ArticleId><ArticleId IdType="pmc">PMC7693600</ArticleId><ArticleId IdType="pubmed">33142686</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HI, Chio CC, Lin JY. Inhibition of EV71 by curcumin in intestinal epithelial cells. PLoS ONE. 2018;13(1):e0191617. doi: 10.1371/journal.pone.0191617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0191617</ArticleId><ArticleId IdType="pmc">PMC5784943</ArticleId><ArticleId IdType="pubmed">29370243</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Lin L, Chen Y, et al. Curcumin inhibits the replication of Enterovirus 71 in vitro. Acta Pharm Sin B. 2014;4(4):284&#x2013;294. doi: 10.1016/j.apsb.2014.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2014.06.006</ArticleId><ArticleId IdType="pmc">PMC4629085</ArticleId><ArticleId IdType="pubmed">26579397</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CJ, Chang L, Chu HW, et al. High amplification of the antiviral activity of curcumin through transformation into carbon quantum dots. Small. 2019;15(41):e1902641. doi: 10.1002/smll.201902641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smll.201902641</ArticleId><ArticleId IdType="pubmed">31468672</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TY, Chen DY, Wen HW, et al. Inhibition of enveloped viruses infectivity by curcumin. PLoS ONE. 2013;8(5):e62482. doi: 10.1371/journal.pone.0062482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0062482</ArticleId><ArticleId IdType="pmc">PMC3641039</ArticleId><ArticleId IdType="pubmed">23658730</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Chen L, Tang M, et al. Revealing the effects of curcumin on SH-SY5Y neuronal cells: a combined study from cellular viability, morphology, and biomechanics. J Agric Food Chem. 2019;67(15):4273&#x2013;4279. doi: 10.1021/acs.jafc.9b00314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.9b00314</ArticleId><ArticleId IdType="pubmed">30929442</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan H, Zhu M, Xiong Q, et al. Regulation of Enterovirus 2A protease-associated viral IRES activities by the cell's ERK signaling cascade: implicating ERK as an efficiently antiviral target. Antiviral Res. 2017;143:13&#x2013;21. doi: 10.1016/j.antiviral.2017.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.03.018</ArticleId><ArticleId IdType="pubmed">28351508</ArticleId></ArticleIdList></Reference><Reference><Citation>Si X, Wang Y, Wong J, et al. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J Virol. 2007;81(7):3142&#x2013;3150. doi: 10.1128/JVI.02028-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02028-06</ArticleId><ArticleId IdType="pmc">PMC1866032</ArticleId><ArticleId IdType="pubmed">17229707</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M, Duan H, Liu J, et al. The multi-targeted kinase inhibitor sorafenib inhibits Enterovirus 71 replication by regulating IRES-dependent translation of viral proteins. Antiviral Res. 2014;106:80&#x2013;85. doi: 10.1016/j.antiviral.2014.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.03.009</ArticleId><ArticleId IdType="pubmed">24680956</ArticleId></ArticleIdList></Reference><Reference><Citation>Petracca M, Quarantelli M, Moccia M, et al. ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): a randomized, controlled trial. Mult Scler Relat Disord. 2021;56:103274. doi: 10.1016/j.msard.2021.103274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103274</ArticleId><ArticleId IdType="pubmed">34583214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren M, Wang Y, Wu X, et al. Curcumin synergistically increases effects of &#x3b2;-interferon and retinoic acid on breast cancer cells in vitro and in vivo by up-regulation of GRIM-19 through STAT3-dependent and STAT3-independent pathways. J Drug Target. 2017;25(3):247&#x2013;254. doi: 10.1080/1061186X.2016.1242132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1061186X.2016.1242132</ArticleId><ArticleId IdType="pubmed">27677346</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Im YH, Jung HH, et al. Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun. 2005;334(2):313&#x2013;318. doi: 10.1016/j.bbrc.2005.06.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.06.093</ArticleId><ArticleId IdType="pubmed">16005433</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Jung HH, Im YH, et al. Interferon-alpha resistance can be reversed by inhibition of IFN-alpha-induced COX-2 expression potentially via STAT1 activation in A549 cells. Oncol Rep. 2006;15(6):1541&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pubmed">16685393</ArticleId></ArticleIdList></Reference><Reference><Citation>Drion CM, van Scheppingen J, Arena A, et al. Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo&#x2014;in search of potential anti-epileptogenic strategies for temporal lobe epilepsy. J Neuroinflammation. 2018;15(1):212. doi: 10.1186/s12974-018-1247-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1247-9</ArticleId><ArticleId IdType="pmc">PMC6056921</ArticleId><ArticleId IdType="pubmed">30037344</ArticleId></ArticleIdList></Reference><Reference><Citation>Namkaew J, Jaroonwitchawan T, Rujanapun N, et al. Combined effects of curcumin and doxorubicin on cell death and cell migration of SH-SY5Y human neuroblastoma cells. In Vitro Cell Dev Biol Anim. 2018;54(9):629&#x2013;639. doi: 10.1007/s11626-018-0288-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11626-018-0288-9</ArticleId><ArticleId IdType="pubmed">30136034</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HI, Lin JY, Chen SH. EV71 infection induces IFN&#x3b2; expression in neural cells. Viruses. 2019;11(12):1121. doi: 10.3390/v11121121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11121121</ArticleId><ArticleId IdType="pmc">PMC6950376</ArticleId><ArticleId IdType="pubmed">31817126</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zheng Z, Shu B, et al. SUMO modification stabilizes Enterovirus 71 polymerase 3D To facilitate viral replication. J Virol. 2016;90(23):10472&#x2013;10485. doi: 10.1128/JVI.01756-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01756-16</ArticleId><ArticleId IdType="pmc">PMC5110190</ArticleId><ArticleId IdType="pubmed">27630238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung YA, Hung CT, Chien KY, et al. Control of the negative IRES trans-acting factor KHSRP by ubiquitination. Nucleic Acids Res. 2017;45(1):271&#x2013;287. doi: 10.1093/nar/gkw1042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1042</ArticleId><ArticleId IdType="pmc">PMC5224474</ArticleId><ArticleId IdType="pubmed">27899653</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Li X, Li P, et al. Enterovirus 71 inhibits cellular type I interferon signaling by inhibiting host RIG-I ubiquitination. Microb Pathog. 2016;100:84&#x2013;89. doi: 10.1016/j.micpath.2016.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2016.09.001</ArticleId><ArticleId IdType="pubmed">27633794</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>